InvestorsHub Logo

Investor2014

04/18/21 4:59 PM

#307491 RE: baltimorebullet #307490

I find if a bit odd that the CMO and Regulatory guy are never present for any presentations and analyst conference calls.

Most biotech calls I attend have the CEO, CFO and CMO saying their piece and taking analyst questions.

We get to hear Sandra running through the figures every quarter, everything else is strictly Missling.

Control freak or the other guys not much use?

nidan7500

04/18/21 5:07 PM

#307492 RE: baltimorebullet #307490

Many job changes involve a measure of hope and few are a sure thing.



IMO-AVXL is working to avoid some kind of issue which we do not see from where we are outside.

Dr.M. and AVXL organization typically move to PREVENT issue(s) (which we cannot see) from developing. Positive Opportunities may arise which only AVXL are aware of b/c they have taken or will act, and it is critical. I see this as the OPPOSITE OF CORRECTIVE ACTION. We probably cannot go where we need to go next w/o structural adjustments, AKA, A PREVENTIVE ACTION.